Report exposes the ghostwriting practice in the pharmaceutical industry
Big Pharma, academics guilty of skewing results for profit, prestige.
May 11, 2011: Marc-André Gagnon and Sergio Sismondo write in The Mark that pharmaceutical companies spend much time and money on promoting their products than on research and development. Ghostwriters publish articles in a positive light while some companies even go as far as creating fake medical journals in which to publish their "research".
"The medical research world has been concerned about the problem of ghost writing for more than a decade. Over the past few years, the issue has been repeatedly raised in the mainstream media. Most of the commentary has focused on the ethics of academics signing their name on papers they did not write and on some of the most egregious actions by pharmaceutical companies.
But these efforts miss the ways in which Big Pharma has developed new forms of medical research to serve its own interests
For the complete article, please click here.
Related individuals, organizations and significant events
For the full report, The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States, please click here.
Posted: May 19, 2011
Public Values (PublicValues.ca) is a project of the Golden Lake Institute and the online publication StraightGoods.ca